<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, Fang et al. developed a CPE-based HTS assay to screen 1280 pharmacologically active compounds and identified niclosamide as a potent JEV inhibitor with micromolar potency.
 <sup>
  <xref ref-type="bibr" rid="ref42">42</xref>
 </sup> The time-of-addition studies showed that niclosamide inhibits JEV at the stage of replication.
</p>
